These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30629123)

  • 21. Is Fat Mass Cross-Sectionally Associated with Cortical Aβ Load in the Human Brain?
    Maltais M; de Souto Barreto P; Rolland Y; Vellas B
    J Nutr Health Aging; 2019; 23(2):207-210. PubMed ID: 30697632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction between physical activity and sleep on cognitive function and brain beta-amyloid in older adults.
    Sewell KR; Rainey-Smith SR; Villemagne VL; Peiffer J; Sohrabi HR; Taddei K; Ames D; Doré V; Maruff P; Laws SM; Masters CL; Rowe CC; Martins RN; Erickson KI; Brown BM
    Behav Brain Res; 2023 Feb; 437():114108. PubMed ID: 36100010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
    Chételat G; Villemagne VL; Bourgeat P; Pike KE; Jones G; Ames D; Ellis KA; Szoeke C; Martins RN; O'Keefe GJ; Salvado O; Masters CL; Rowe CC;
    Ann Neurol; 2010 Mar; 67(3):317-24. PubMed ID: 20373343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ankle-Brachial Index Is Associated with Cerebral β-Amyloid Deposition in Cognitively Normal Older Adults.
    Moon SW; Byun MS; Yi D; Lee JH; Jeon SY; Lee Y; Kee BS; Lee DY;
    J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1141-1148. PubMed ID: 29982493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excessive daytime sleepiness and napping in cognitively normal adults: associations with subsequent amyloid deposition measured by PiB PET.
    Spira AP; An Y; Wu MN; Owusu JT; Simonsick EM; Bilgel M; Ferrucci L; Wong DF; Resnick SM
    Sleep; 2018 Oct; 41(10):. PubMed ID: 30192978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain Amyloid Deposition Is Associated With Lower Instrumental Activities of Daily Living Abilities in Older Adults. Results From the MAPT Study.
    Lilamand M; Cesari M; del Campo N; Cantet C; Soto M; Ousset PJ; Payoux P; Andrieu S; Vellas B;
    J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):391-7. PubMed ID: 26419979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
    Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
    J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced brain amyloid burden in elderly patients with narcolepsy type 1.
    Gabelle A; Jaussent I; Bouallègue FB; Lehmann S; Lopez R; Barateau L; Grasselli C; Pesenti C; de Verbizier D; Béziat S; Mariano-Goulart D; Carlander B; Dauvilliers Y; ;
    Ann Neurol; 2019 Jan; 85(1):74-83. PubMed ID: 30387527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical Activity and Amyloid-β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment.
    de Souto Barreto P; Andrieu S; Payoux P; Demougeot L; Rolland Y; Vellas B;
    J Am Geriatr Soc; 2015 Aug; 63(8):1634-9. PubMed ID: 26200930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid-beta and depression in healthy older adults: a systematic review.
    Harrington KD; Lim YY; Gould E; Maruff P
    Aust N Z J Psychiatry; 2015 Jan; 49(1):36-46. PubMed ID: 25414381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
    Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
    Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.
    Perin S; Harrington KD; Lim YY; Ellis K; Ames D; Pietrzak RH; Schembri A; Rainey-Smith S; Salvado O; Laws SM; Martins RN; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Affect Disord; 2018 Mar; 229():269-274. PubMed ID: 29329059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
    Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
    Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association Between Early Age-Related Hearing Loss and Brain β-Amyloid.
    Golub JS; Sharma RK; Rippon BQ; Brickman AM; Luchsinger JA
    Laryngoscope; 2021 Mar; 131(3):633-638. PubMed ID: 32644260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.